Login / Signup

Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.

Masataka UmedaKanako KojimaToru MichitsujiYoshika TsujiToshimasa ShimizuShoichi FukuiRemi SumiyoshiTomohiro KogaShin-Ya KawashiriIwamoto NaokiTakashi IagawaMami TamaiTomoki OriguchiMasako FuruyamaMasahiko TsuboiNaoki MatsuokaAkitomo OkadaToshiyuki AramakiAtsushi Kawakami
Published in: Modern rheumatology (2024)
Keyphrases
  • systemic lupus erythematosus
  • disease activity
  • rheumatoid arthritis patients
  • ankylosing spondylitis
  • juvenile idiopathic arthritis
  • rheumatoid arthritis